Is it Time to Dump CV Sciences Inc (CVSI) Stock After it Has Fallen 0.00% in a Week?

CV Sciences Inc (CVSI) stock is unmoved 0.00% over the past week and gets a Bearish rating from InvestorsObserver Sentiment Indicator.

CV Sciences Inc has a Bearish sentiment reading. Find out what this means for you and get the rest of the rankings on CVSI!

See Full CVSI Report

What is Stock Sentiment?

When making investment decisions, sentiment gives a good overview of what stocks investors currently favor. Sentiment incorporates short-term technical analysis into its score and does not encompass any fundamental analysis such as profitability of the company. This means that earnings updates and other news can greatly impact overall sentiment. Sentiment is how investors, or the market, feels about a stock. There are lots of ways to measure sentiment. At the core, sentiment is pretty easy to understand. If a stock is going up, investors must be bullish, while if it is going down, sentiment is bearish. InvestorsObserver’s Sentiment Indicator looks at price trends over the past week and also considers changes in volume. Increasing volume can mean a trend is getting stronger, while decreasing volume can mean a trend is nearing a conclusion. For stocks that have options, our system also considers the balance between calls, which are often bets that the price will go up, and puts, which are frequently bets that the price will fall.

What's Happening With CVSI Stock Today?

CV Sciences Inc (CVSI) stock is flat -0.62% while the S&P 500 has risen 0.23% as of 11:33 AM on Friday, Feb 9. CVSI is unchanged $0.00 from the previous closing price of $0.04 on volume of 69,766 shares. Over the past year the S&P 500 has risen 21.65% while CVSI is down -20.00%. CVSI earned $0.01 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 3.54.

More About CV Sciences Inc

CV Sciences Inc is a pharmaceutical company. The group operates in two segments consumer products and specialty pharmaceutical. The consumer products segment develops, manufactures and markets products based on hemp-based Cannabidiol (CBD). Whereas the specialty pharmaceutical segment is developing drug candidates which use CBD as a primary active ingredient. Click Here to get the full Stock Report for CV Sciences Inc stock.